相关实验视频
Updated: Jul 6, 2025
09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.7K
一个由血栓激素驱动的神经网络可以诊断抗脂综合征,而无需中断抗凝血
Romy M W de Laat-Kremers1, Denis Wahl2, Stéphane Zuily2
1Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, The Netherlands.
Blood advances
|January 1, 2024
概括
人工神经网络 (NN) 可以通过使用K维生素对抗剂 (VKA) 治疗患者的血栓生成 (TG) 试验结果来诊断抗脂综合征 (APS). 这种诊断工具显示出高准确度,无需停止抗凝药治疗.
科学领域:
- 血液学 血液学 血液学
- 人工智能的人工智能
- 医学诊断 医学诊断 医学诊断
背景情况:
- 抗脂综合征 (APS) 的特点是血栓形成,这种情况通常在血栓事件后被诊断出来.
- 目前的APS诊断标准包括特定抗体测试,抗凝剂治疗可能会使其复杂化.
- 血生成 (TG) 测试是全球静血测试,其中高水平与血栓形成相关.
研究的目的:
- 开发一种能够在接受维生素K抗剂 (VKA) 治疗的患者中诊断APS的人工神经网络 (NN).
- 使用TG测试结果和血栓动态参数作为NN模型的输入.
- 为了验证NN在VKA治疗患者的独立队列中的诊断性能.
主要方法:
- 五名NN使用48名VKA治疗的APS患者和64名VKA治疗的对照者的TG和血栓动态参数进行了训练.
- 最好的两个NN被根据性能指标 (准确性,灵敏性,特异性) 选择.
- 选择的NN在33名接受VKA治疗的APS患者和62名接受VKA治疗的对照组的独立队列上得到了验证.
主要成果:
- 在初始培训期间,表现最好的NN实现了高精度 (96%),灵敏度 (96%-98%),和特异性 (95%-97%).
- 独立的验证表明,对于一个选择的NN.N.,敏感度为88%,特异性为94%.
- 开发的NN实现了92%的整体准确性,用于诊断VKA治疗个体的APS.
结论:
- 结合使用TG测定和NN方法,可以在接受VKA治疗的患者中进行准确的APS诊断.
- 无血作为潜在的查和诊断工具,用于血栓形成,特别是在服用抗凝药的患者中.
- 这种方法消除了在诊断APS时停止抗凝剂治疗的必要性,简化了诊断过程.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
526
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
526
01:16Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
01:24Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922